Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 634.80 1.41% 628.60 0.62%
 More Info 
AJANTA PHARMA 1,025.90 0.10% 1,023.35 -0.46%
 More Info 
ALEMBIC PHARMA 530.00 -2.61% 530.30 -2.29%
 More Info 
BIOCON 613.60 -0.07% 613.40 -0.05%
 More Info 
CADILA HEALTHCARE 329.75 0.30% 329.55 0.24%
 More Info 
CIPLA 559.80 -0.40% 558.55 -0.56%
 More Info 
DIVIS LABORATORIES 1,740.60 3.03% 1,742.70 3.30%
 More Info 
GLENMARK PHARMA 635.30 0.92% 636.40 1.13%
 More Info 
INDOCO REMEDIES 217.40 9.58% 218.65 10.07%
 More Info 
IPCA LABS 967.00 -0.60% 965.30 -1.04%
 More Info 
J.B.CHEMICALS 348.25 0.96% 347.90 1.27%
 More Info 
LUPIN 864.50 0.02% 864.25 -0.39%
 More Info 
NATCO PHARMA 540.15 0.81% 539.95 0.48%
 More Info 
NIFTY 50 Not Listed 11,726.15 1.30%
 More Info 
ORCHID PHARMA LTD 5.21 -4.93% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 205.35 4.50% 205.35 5.96%
 More Info 
PIRAMAL ENTERPRISES 2,585.70 1.96% 2,585.70 1.84%
 More Info 
S&P BSE SENSEX 39,054.68 1.27% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 474.45 -0.23% 474.75 -0.21%
 More Info 
SUN PHARMA 469.15 0.14% 469.35 0.17%
 More Info 
TORRENT PHARMA 1,778.70 -1.72% 1,779.85 -1.46%
 More Info 
WOCKHARDT 428.00 0.15% 426.85 -0.06%
 More Info 

BSE prices: April 24, 2019  (Close)    NSE prices: April 24, 2019  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 9,448.2 (up 0.6%). The index is down 8.3% over the last 30 days. And over the last 1 year, it has gained 0.6%.

Within the Indian Pharma sector, the top gainers were INDOCO REMEDIES (up 9.6%) and PANACEA BIOTECH (up 4.5%). On the other hand, ORCHID PHARMA LTD (down 4.9%) and ALEMBIC PHARMA (down 2.6%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 11,726.2 (up 1.3%).




Today's Market

Rising Crude Oil Prices, Developments in the Automobile Sector, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session on a strong note yesterday. Gains were largely seen in the oil & gas sector and telecom sector.

Related Views on News

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

GLENMARK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 11.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, GLENMARK PHARMA has posted a net profit of Rs 1 bn (up 11.1% YoY). Sales on the other hand came in at Rs 26 bn (up 15.9% YoY). Read on for a complete analysis of GLENMARK PHARMA's quarterly results.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Apr 24, 2019 (Close)

COMPARE COMPANY

MARKET STATS